Group | Patients with stroke | CU without stroke (n = 37) | p¥ | |||
---|---|---|---|---|---|---|
PSNC (n = 25) | PSCI (n = 12) | p* | Total (n = 37) | |||
Demographics | ||||||
Age, years | 71.3 ± 8.0 | 74.7 ± 8.0 | 0.238 | 72.4 ± 8.1 | 72.6 ± 8.2 | 0.920 |
Sex, female | 6 (24.0%) | 6 (50.0%) | 0.228 | 12 (32.4%) | 13 (35.1%) | 1.000 |
Education, years | 9.4 ± 4.2 | 6.9 ± 5.1 | 0.128 | 8.6 ± 4.6 | 10.0 ± 4.8 | 0.196 |
APOE, e4 carrier | 6 (24.0%) | 7 (58.3%) | 0.093 | 13 (35.1%) | 7 (18.9%) | 0.116 |
Hypertension | 16 (64.0%) | 11 (91.7%) | 0.168 | 27 (73.0%) | 17 (45.9%) | 0.033 |
Diabetes | 4 (16.0%) | 7 (58.3%) | 0.024 | 11 (29.7%) | 11 (29.7%) | 1.000 |
Cognition | ||||||
K-MMSE | 26.1 ± 3.8 | 22.3 ± 3.7 | 0.008 | 24.9 ± 4.1 | 27.9 ± 1.9 | < 0.001 |
CDR-SOB | 0.90 ± 0.54 | 2.71 ± 1.36 | 0.001 | 1.49 ± 1.22 | 0.20 ± 0.36 | < 0.001 |
Aβ deposition | ||||||
Aβ positivity | 4 (16.0%) | 7 (58.3%) | 0.024 | 11 (29.7%) | 6 (16.2%) | 0.167 |
cSVD burden | ||||||
WMH severity | 0.228 | 0.010 | ||||
Moderate WMH | 5 (20.0%) | 4 (33.3%) | 9 (24.3%) | 2 (5.4%) | ||
Severe WMH | 1 (4.0%) | 2 (16.7%) | 3 (8.1%) | 0 (0.0%) | ||
Lacune counts | 0.7 ± 1.4 | 0.7 ± 1.1 | 0.977 | 0.7 ± 1.3 | 0.1 ± 0.3 | 0.006 |
MB counts | 0.6 ± 1.4 | 0.6 ± 1.1 | 0.972 | 0.6 ± 1.3 | 0.4 ± 1.2 | 0.458 |
CAA markers | ||||||
cSS | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||
Strictly lobar MB | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |